Application no. and date | 13865442.1 (espacenet) (Federated) (European Patent Register), 20131217 | Patent/reg. no. and date | DK/EP 2931752, 20190814 | Publication date | 20151021 | Priority no. and date | US 201261738008 P, 20121217 | EP pub. no. and date |
EP 2931752 20151021 | Effective date | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East New York, NY 10001-2192, US | Applicant ref. no. | RE447377DK00 | Inventor | UGER, Robert Adam, 20 Reditt Court
Richmond Hill, ON L4C 7S4, CA, SLAVOVA-PETROVA, Penka Slavtcheva, 1207-2261 Lake Shore Blvd West
Toronto, ON M8V 3X1, CA, PANG, Xinli, 190 Mountainash Road
Brampton, ON L6R 3H1, CA | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 38/16 (2006.01) , A61K 38/45 (2006.01) , A61P 35/02 (2006.01) , C07K 14/705 (2006.01) , C07K 16/00 (2006.01) , C07K 19/00 (2006.01) , C12N 15/62 (2006.01) , A61K 38/00 (2006.01) | Title | BEHANDLING AF CD47+ SYGDOMSCELLER MED SIRP-ALPHA-FC-FUSIONER | Int. application no. | CA2013001046 | Int. publication no. | WO2014094122 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|